MiddleBrook expanding promotion of Moxatag through IncreaseRx program

WESTLAKE, Texas MiddleBrook Pharmaceuticals plans to promote its extended-release antibiotic by expanding a Web-based marketing program, the drug maker announced Wednesday.

IncreaseRx is a virtual sales-contract organization that gives healthcare professionals access to electronic sampling, learning and education tools. The company has entered an agreement with DoctorDirectory.com, its promotion partner for Moxatag (amoxicillin), and plans to use Web-based educational and promotional tactics to reach prescribers with sales and marketing messages for the drug.

“Under this expanded IncreaseRx program, physicians who previously received Moxatag samples and information from MiddleBrook field sales representatives will be able to request samples and receive important product information electronically,” MiddleBrook acting president and CEO Dave Becker said. “We will be able to reach more than 150,000 physicians across the nation through the expanded IncreaseRx program for Moxatag.”